Clinical Scorecard: Medium-chain triglycerides enhance cognitive function and metabolic processes in Alzheimer’s disease mouse models
At a Glance
Category
Detail
Condition
Alzheimer’s disease
Key Mechanisms
MCT supplementation improves cognition and systemic metabolism without elevating circulating ketone levels; modulates hippocampal gene expression related to mitochondrial function, synaptic structure, and insulin signalling; enhances peripheral insulin response; distinct from ketogenic diet effects
Target Population
Individuals with Alzheimer’s disease or at risk, modeled in AD mouse models (3xTg-AD and 5xFAD)
Care Setting
Dietary intervention settings, potentially clinical nutrition or research contexts
Key Highlights
MCT supplementation and ketogenic diet both improve hippocampal-dependent spatial learning and memory in AD mouse models.
MCT supplementation does not elevate circulating ketones but enhances peripheral insulin response, contrasting with ketogenic diet effects.
MCT and ketogenic diets partially reverse hepatic metabolic abnormalities in AD mice via distinct mechanisms.
Guideline-Based Recommendations
Diagnosis
Consider peripheral metabolic dysfunctions such as insulin resistance as contributors to AD risk.
Management
Dietary supplementation with medium-chain triglycerides can improve cognitive function and systemic metabolism in AD.
Ketogenic diets may improve cognition but can increase hyperglycaemia, body weight, and adiposity in AD models.
Monitoring & Follow-up
Monitor cognitive function and metabolic parameters including insulin response and lipid metabolism during dietary interventions.
Risks
Ketogenic diets may unveil latent metabolic vulnerabilities, increasing hyperglycaemia and proinflammatory hepatic gene expression.
Patient & Prescribing Data
Patients with Alzheimer’s disease or mild cognitive impairment
MCT supplementation improves memory and metabolic profiles without requiring carbohydrate restriction or inducing ketosis; ketogenic diets induce ketosis but may have adverse metabolic effects.
Clinical Best Practices
Use MCT supplementation as a dietary strategy to enhance cognition and peripheral metabolism in AD without elevating ketones.
Evaluate individual metabolic status before initiating ketogenic diets due to potential adverse effects on glucose metabolism and inflammation.
Consider the stage of Alzheimer’s disease when selecting dietary interventions, as effects may vary between early and late stages.
by Paule E H M’Bra, Laura K Hamilton, Gaël Moquin-Beaudry, Chenicka L Mangahas, Federico Pratesi, Anne Castonguay, Sophia Mailloux, Manon Galoppin, Jessica Avila Lopez, Megan Bernier, Marta Turri, Marian Mayhue, Anne Aumont, Martine Tetreault, Stephen C Cunnane, Karl J L Fernandes
